COVID Booster Shots Carry ‘Increased Myocarditis Risk’ for Young Adults: Nordic Study
Among males, a third dose of the Pfizer or Moderna vaccine was associated with an ‘increased incidence rate of myocarditis’ within 28 days.
Booster vaccination against COVID-19 is linked to a higher risk of heart inflammation among adolescents, according to a recent study using data from several Nordic nations.
In total, 1,533 cases of myocarditis were identified with the study concluding that the “booster dose is associated with increased myocarditis risk in adolescents and young adults.”
Among males, a third dose of the Pfizer or Moderna vaccine was associated with an “increased incidence rate of myocarditis” within 28 days of inoculation compared to a longer period after the second dose.
The study noted that the association of myocarditis with COVID-19 mRNA vaccines has appeared “strongest in male adolescents and younger males and after the second dose.”
Significant Spike in Cases
Cases of myocarditis among vaccinated individuals in the United States spiked within the first year of the COVID-19 vaccination campaign, according to a study published in late January that looked at data from the Vaccine Adverse Event Reporting System (VAERS).
Related Stories
“We found the number of myocarditis reports in VAERS after COVID-19 vaccination in 2021 was 223 times higher than the average of all vaccines combined for the past 30 years. This represented a [2,500 percent] increase in the absolute number of reports in the first year of the campaign when comparing historical values prior to 2021,” the U.S. study said.
Roughly 50 percent of myocarditis cases occurred among youths and 69 percent of affected individuals were males. Out of a total of 3,078 COVID-19 vaccine-induced myocarditis cases as of August 2023, 76 percent resulted in emergency care and hospitalization, and 3 percent died.
New studies are being published looking at reducing myocarditis risk when vaccinating adolescents against COVID-19, appearing to confirm the fact that such a risk exists for the shots.
Carditis is the general term for inflammation of the heart.
The study referred to adolescents as a “vulnerable population” while pointing out that “previous studies indicate an increased carditis risk among adolescents following the two-dose messenger RNA COVID-19 vaccine.”
COVID-19 and Myocarditis
There have been suggestions that COVID-19 infections cause more myocarditis cases than the vaccines.
Dr. Daniel Jernigan from the U.S. Centers for Disease Control and Prevention recently testified at a hearing of the House Committee on Oversight and Accountability Select Subcommittee on the Coronavirus Pandemic. In his testimony, Dr. Jernigan claimed that the risk of getting myocarditis is “much lower among those vaccinated than among those that are unvaccinated.”
However, cardiologist Dr. Peter McCullough disputes the claim that COVID-19 infections cause myocarditis.
The cardiologist called claims of the COVID-19 virus infecting the heart and causing myocarditis “false claims made from automated hospital data and not adjudicated, autopsy proven cases.”
“The COVID-19 vaccines install mRNA in the heart and the Spike protein directly damages and incites inflammation into the heart muscle causing the pathophysiology we see every day in cardiology practice,” he wrote.
They called on world governments to impose a “global moratorium” on the COVID-19 vaccines “given the well-documented [serious adverse events] and unacceptable harm-to-reward ratio.”
The authors also recommended an “immediate removal” of COVID-19 vaccines from the childhood immunization schedule, pointing out that children were at very low risk of infection.
This article has been archived for your research. The original version from Epoch Times can be found here.
